ONCOLOGY
Cancer still remains a major public health problem in the world. Therefore, the development of new therapeutic strategies is highly awaited. Cellvax conducts preclinical studies.
OSTEOARTHRITIS
Osteoarthritis affects large number of population including young adults. Several relevant animal models are available at Cellvax to validate novel treatments.
Toxicity PK / Biodistributions studies
A complete toxicity experiment can be proposed at Cellvax in both rodent and nonrodents. In order to understand the pharmacokinetics (PK) of your innovating drugs, we propose a bio-distribution and PK studies in animal models
Company Office
Cellvax, SAS
Villejuif Bio Park
1, mail du Professeur Georges Mathé
94800, Villejuif
France
(GPS address: 10 rue Guy Moquet 94800 Villejuif France)
Tel: + 33 (0) 9 52 30 26 20
Cell: +33 (0) 6 71 43 47 51
Fax: + 33 (0) 9 52 30 26 20
E-mail: contact@cellvax-pharma.com